- Recent Funding
- Investors
- Oxford Science Enterprises
Oxford Science Enterprises portfolio
Oxford Science Enterprises has 18 portfolio companies on record at Recent Funding, with 11 investments in the last 12 months.
About this page
It is a venture studio based in Oxford, GB, founded in 2015. It led 4 of the 27 rounds it joined. Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Eli Lilly and 5 others. By category, its portfolio leans toward Health and bio (10) and Manufacturing and industrial (6). It has co-invested with University of Oxford, Syncona Partners LLP and GV, most often University of Oxford (6 rounds).
About Oxford Science Enterprises
What Oxford Science Enterprises invests in
- Health and bio · 10 · 56%
- Manufacturing and industrial · 6 · 33%
- Robotics and hardware · 6 · 33%
- Climate and energy · 3 · 17%
- Education · 3 · 17%
- AI infrastructure and compute · 2 · 11%
- Data and analytics · 2 · 11%
- Developer tools and cloud · 1 · 6%
Oxford Science Enterprises recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $60M | Global Brain Corporation, 4BIO Capital (lead), Eli Lilly +5 | ||
| Series A · $90M | Cancer Research Horizons, University of Oxford, RA Capital Management (lead) +1 | ||
| Series A · $29.9M | Volta Energy Technologies, GGF, Orano Venture Fund (lead) +6 | ||
| Series B+ · $310M | Jefferson Life Sciences, Novo Holdings (lead), Janus Henderson Investors +6 | ||
| Series B+ · $125M | Hudson River Trading, Bullhound Capital (lead), Cambridge Innovation Capital +6 | ||
| Series A · $47M · lead | Timothy Garnett, Civilization Ventures, Isomer Capital +6 | ||
| Seed · $5M · lead | HL Energy Ventures (lead) | ||
| Series A · $100M | Lightstone Ventures, NEA (lead), 8VC +2 |
How Oxford Science Enterprises invests
Oxford Science Enterprises portfolio companies
OOyster Therapeutics$60MSeries A · Nov 2026
AAlethio Therapeutics$90MSeries A · Nov 2026
FFluoRok$29.9MSeries A · Nov 2026
OOMass Therapeutics$310MSeries B+ · Oct 2026
SSalience Labs$125MSeries B+ · Oct 2026
SSensible Biotechnologies$47MSeries A · Oct 2026
MMCatalysis$5MSeed · Sep 2026
AAmber Therapeutics$100MSeries A · Jul 2026
RRQ Bio$115MSeries A · Jun 2026
OOxford Quantum Circuits$350MSeries B+ · Jun 2026QQuantum Motion$160MSeries B+ · May 2026
UUltromics$55MSeries B+ · Aug 2025
GGrey Wolf Therapeutics$50MSeries B+ · May 2024
OONI$75MSeries B+ · Jan 2022
BBibli U$10MSeries A · Apr 2020
QQuantrolOxbacker
OOpsydiabacker
OOxford Flowbacker
| Company | Round with Oxford Science Enterprises | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $60M | $60M | Nov 10, 2026 Series A |
Health and bio |
Series A · $90M | $90M | Nov 5, 2026 Series A |
Health and bio |
Series A · $29.9M | $29.9M | Nov 5, 2026 Series A |
Health and bio |
Series B+ · $310M | $422.51M | Oct 15, 2026 Series B+ |
AI infrastructure and compute |
Series B+ · $125M | $166.5M | Oct 14, 2026 Series B+ |
Health and bio |
Series A · $47M · lead | $51.2M | Oct 6, 2026 Series A |
Robotics and hardware |
Seed · $5M · lead | $5M | Sep 9, 2026 Seed |
Health and bio |
Series A · $100M | $200M | Jul 24, 2026 Series A |
Health and bio |
Series A · $115M | $115M | Jun 24, 2026 Series A |
AI infrastructure and compute |
Series B+ · $350M | $497M | Jun 2, 2026 Series B+ |
Robotics and hardware |
Series B+ · $160M | $220.21M | May 7, 2026 Series B+ |
Health and bio |
Series B+ · $55M | $111M | Aug 11, 2025 Series B+ |
Health and bio |
Series B+ · $50M | $99M | May 23, 2024 Series B+ |
Health and bio |
Series B+ · $75M | $75M | Jan 29, 2022 Series B+ |
Data and analytics |
Series A · $10M | $80.65M | Jun 2, 2026 round |
Data and analytics |
backer | $13.45M | Oct 22, 2026 Series A |
Robotics and hardware |
backer | undisclosed | Aug 1, 2025 Series A |
Robotics and hardware |
backer | $25M | Dec 5, 2024 Series B+ |
Most frequent co-investors
UUniversity of Oxford6 shared rounds · last Nov 5, 2026
SSyncona Partners LLP4 shared rounds · last Nov 10, 2026
GGV4 shared rounds · last Oct 15, 2026
BBritish Business Bank4 shared rounds · last Oct 14, 2026
BBritish Patient Capital4 shared rounds · last May 23, 2024
CCambridge Innovation Capital3 shared rounds · last Oct 14, 2026
- OOTIF3 shared rounds · last Jun 2, 2026
IInkef3 shared rounds · last May 7, 2026
PParkwalk Advisors3 shared rounds · last May 7, 2026
SSanofi Ventures2 shared rounds · last Oct 15, 2026
NNorthpond Ventures2 shared rounds · last Oct 15, 2026
SSBI Investment2 shared rounds · last Oct 14, 2026
Similar investors
AAtlas Venture18 companies · 3 deals in 12 mo
KK Fund18 companies · 3 deals in 12 mo
VVerve Ventures18 companies · 3 deals in 12 mo
BBioInnovation Institute Venture Lab18 companies · 1 deal in 12 moEEQT Life Sciences19 companies · 6 deals in 12 mo
Rredalpine19 companies · 5 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 27 rounds on Recent Funding that name Oxford Science Enterprises. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Oxford Science Enterprises, which is a subset of its real portfolio. API: /api/v1/investors/oxford-science-enterprises (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy